Cargando…
Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase
The p53 gene is mutated in more than 50% of human tumors. Mutant p53 exerts an oncogenic function and is often highly expressed in cancer cells due to evasion of proteasome-dependent degradation. Thus, reactivating proteasome-dependent degradation of mutant p53 protein is an attractive strategy for...
Autores principales: | Yan, Wensheng, Jung, Yong-Sam, Zhang, Yanhong, Chen, Xinbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130519/ https://www.ncbi.nlm.nih.gov/pubmed/25116336 http://dx.doi.org/10.1371/journal.pone.0103497 |
Ejemplares similares
-
Pirh2 E3 Ubiquitin Ligase Modulates Keratinocyte Differentiation Through p63
por: Jung, Yong-Sam, et al.
Publicado: (2012) -
The Role of E3 Ligase Pirh2 in Disease
por: Daks, Alexandra, et al.
Publicado: (2022) -
Role of Pirh2 in Mediating the Regulation of p53 and c-Myc
por: Hakem, Anne, et al.
Publicado: (2011) -
Recognition of an Ala-rich C-degron by the E3 ligase Pirh2
por: Wang, Xiaolu, et al.
Publicado: (2023) -
Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin
por: Hu, Xuqiao, et al.
Publicado: (2021)